148 related articles for article (PubMed ID: 32287422)
21. Extent of intramolecular π-stacks in aqueous solution in mixed-ligand copper(II) complexes formed by heteroaromatic amines and several 2-aminopurine derivatives of the antivirally active nucleotide analog 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
Gómez-Coca RB; Blindauer CA; Sigel A; Operschall BP; Holý A; Sigel H
Chem Biodivers; 2012 Sep; 9(9):2008-34. PubMed ID: 22976988
[TBL] [Abstract][Full Text] [Related]
22. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
Magee WC; Evans DH
Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
[TBL] [Abstract][Full Text] [Related]
23. Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro.
Holý A; Votruba I; Merta A; Cerný J; Veselý J; Vlach J; Sedivá K; Rosenberg I; Otmar M; Hrebabecký H
Antiviral Res; 1990 Jun; 13(6):295-311. PubMed ID: 1699493
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains.
Lebeau I; Andrei G; Krecmerová M; De Clercq E; Holy A; Snoeck R
Antimicrob Agents Chemother; 2007 Jun; 51(6):2268-73. PubMed ID: 17420214
[TBL] [Abstract][Full Text] [Related]
26. Macrophage activation by antiviral acyclic nucleoside phosphonates in dependence on priming immune stimuli.
Zídek Z; Franková D; Holý A
Int J Immunopharmacol; 2000 Dec; 22(12):1121-9. PubMed ID: 11137619
[TBL] [Abstract][Full Text] [Related]
27. Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine.
Naesens L; Andrei G; Votruba I; Krecmerová M; Holý A; Neyts J; De Clercq E; Snoeck R
Biochem Pharmacol; 2008 Oct; 76(8):997-1005. PubMed ID: 18773877
[TBL] [Abstract][Full Text] [Related]
28. Quantification of isomeric equilibria formed by metal ion complexes of 8-[2-(phosphonomethoxy)ethyl]-8-azaadenine (8,8aPMEA) and 9-[2-(phosphonomethoxy)ethyl]-8-azaadenine (9,8aPMEA). Derivatives of the antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
Gómez-Coca RB; Kapinos LE; Holý A; Vilaplana RA; González-Vílchez F; Sigel H
J Biol Inorg Chem; 2004 Dec; 9(8):961-72. PubMed ID: 15503234
[TBL] [Abstract][Full Text] [Related]
29. N(4)-Acyl derivatives as lipophilic prodrugs of cidofovir and its 5-azacytosine analogue, (S)-HPMP-5-azaC: chemistry and antiviral activity.
Krečmerová M; Pohl R; Masojídková M; Balzarini J; Snoeck R; Andrei G
Bioorg Med Chem; 2014 May; 22(10):2896-906. PubMed ID: 24731540
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Anti-HIV Activity of Guanine Modified Fluorinated Acyclic Nucleoside Phosphonate Derivatives.
Luo M; Groaz E; De Jonghe S; Schols D; Herdewijn P
Chem Biodivers; 2019 Feb; 16(2):e1800532. PubMed ID: 30431702
[TBL] [Abstract][Full Text] [Related]
31. Approaches to tyrosine-linked peptidomimetic prodrugs of (S)-HPMP-based acyclic nucleoside phosphonates.
Zakharova VM; Krylov IS; Serpi M; Kashemirov BA; McKenna CE
Phosphorus Sulfur Silicon Relat Elem; 2011; 186(4):968-969. PubMed ID: 21566698
[TBL] [Abstract][Full Text] [Related]
32. Acyclic nucleoside phosphonate antivirals activate gene expression of monocyte chemotactic protein 1 and 3.
Potmesil P; Holý A; Kmonícková E; Krízková J; Zídek Z
J Biomed Sci; 2007 Jan; 14(1):59-66. PubMed ID: 17033877
[TBL] [Abstract][Full Text] [Related]
33. Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals.
Krecmerova M
Mini Rev Med Chem; 2017; 17(10):818-833. PubMed ID: 28215138
[TBL] [Abstract][Full Text] [Related]
34. Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.
Roux L; Priet S; Payrot N; Weck C; Fournier M; Zoulim F; Balzarini J; Canard B; Alvarez K
Eur J Med Chem; 2013 May; 63():869-81. PubMed ID: 23603046
[TBL] [Abstract][Full Text] [Related]
35. Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes.
Zídek Z; Potmesil P; Holý A
Toxicol Appl Pharmacol; 2003 Nov; 192(3):246-53. PubMed ID: 14575642
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and substrate properties towards HIV-1 reverse transcriptase of new diphosphate analogues of 9-[(2-phosphonomethoxy)ethyl]adenine.
Laux WH; Priet S; Alvarez K; Peyrottes S; Périgaud C
Antivir Chem Chemother; 2018; 26():2040206618757636. PubMed ID: 29436843
[TBL] [Abstract][Full Text] [Related]
37. Acyclic adenine nucleoside phosphonates in plasma determined by high-performance liquid chromatography with fluorescence detection.
Naesens L; Balzarini J; De Clercq E
Clin Chem; 1992 Apr; 38(4):480-5. PubMed ID: 1568310
[TBL] [Abstract][Full Text] [Related]
38. The synthesis and antiviral properties of acyclic nucleoside analogues with a phosphonomethoxy fragment in the side chain.
Khandazhinskaya A; Yasko M; Shirokova E
Curr Med Chem; 2006; 13(24):2953-80. PubMed ID: 17073640
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of purine N9-[2-hydroxy-3-O-(phosphonomethoxy)propyl] derivatives and their side-chain modified analogs as potential antimalarial agents.
Krečmerová M; Dračínský M; Hocková D; Holý A; Keough DT; Guddat LW
Bioorg Med Chem; 2012 Feb; 20(3):1222-30. PubMed ID: 22249123
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of acyclic nucleoside phosphonates.
Holý A
Curr Protoc Nucleic Acid Chem; 2005 Oct; Chapter 14():Unit 14.2. PubMed ID: 18428938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
